The reduction of ruthenium(III) complexes with triazolopyrimidine ligands by ascorbic acid and mechanistic insight into their action in anticancer therapy-Reference-Cited by-同舟云学术

The reduction of ruthenium(III) complexes with triazolopyrimidine ligands by ascorbic acid and mechanistic insight into their action in anticancer therapy

Published:2019-01 Issue: Volume:484 Page:305-310
ISSN:0020-1693
Container-title:Inorganica Chimica Acta
language:en
Short-container-title:Inorganica Chimica Acta

Author:

Wiśniewska Joanna,Fandzloch Marzena,Łakomska Iwona

Publisher

Elsevier BV

Subject

Materials Chemistry,Inorganic Chemistry,Physical and Theoretical Chemistry

Reference43 articles.

1. Medicinal Application of Coordination Chemistry;Jones,2007

2. Chemistry and Biochemistry of a Leading Anticancer Drug;Lippert Cisplatin,1999

3. Metal-Ligand Exchange Kinetics in Platinum and Ruthenium Complexes

4. Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design

5. Anti-proliferative activity and mechanism of action of titanocene dichloride

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in the Synthesis of Triazolopyrimidines;Current Organic Chemistry;2024-12

2. Nanostructured mesoporous silica carriers for platinum-based conjugates with anti-inflammatory agents;Biomaterials Advances;2024-12

3. A new strategy to simultaneously optimize Seebeck coefficient and electrical conductivity of PEDOT:PSS polymer via L-ascorbic acid;Synthetic Metals;2024-11

4. Emergence of metal-based anticancer therapeutics: A promising perspective;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

5. Recent Synthetic and Biological Developments on 1,2,4‐Triazolopyrimidines;ChemistrySelect;2023-09-04